Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

KKRT vs FHI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

FHI Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 9–1 Matrix Metrics)

FHI Overall Winner 6-Pillar Tally: KKRT 0 – 5 FHI (1 Tie) Matrix Metrics: KKRT 1 – 9 FHI

As of Nov 17, 2026, Federated Hermes, Inc. (FHI) is the stronger overall head-to-head candidate over KKR & Co. Inc. 6.875% Subordinated Notes due 2065 (KKRT) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KKRT carries a Unified Composite Score of 43.2/100 (HOLD) at $22.37 (N/M Forward P/E, N/A operating margin), whereas FHI carries 49.8/100 (HOLD) at $61.28 (10.5x Forward P/E, 27.8% operating margin).

  • Technical & Structure Timing Caution: KKRT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.0); meanwhile FHI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About KKRT vs FHI
KKRT NYSE
KKR & Co. Inc. 6.875% Subordinated Notes due 2065
Investment Advice
$22.37
+1.41% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.25β · 16% Vol
Unified Composite Score
43.2 / 100 HOLD
Tech 46.0 Fund 45.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -0.9%) with fading momentum, RSI 47
RSI-14: 47.0 · SMA20: $22.62 · SMA50: $22.77
FHI NYSE Head-to-Head Winner
Federated Hermes, Inc.
Investment Advice
$61.28
-2.4% 1D
Market Cap $4.7B
TTM Revenue $1.97B
Forward P/E 10.5x
Beta / 30D Vol 0.57β · 38% Vol
Unified Composite Score
49.8 / 100 HOLD
Tech 42.0 Fund 47.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 51
RSI-14: 51.4 · SMA20: $61.10 · SMA50: $58.67

6-Pillar Scorecard Institutional Category Breakdown (KKRT 0 – 5 FHI)

Columns: Metric · KKRT · FHI
1. Valuation Multiples FHI
Forward P/E N/M 10.5x
Trailing P/E N/M 11.5x
PEG Ratio N/M 1.50x
EV / Revenue N/M 2.4x
2. Growth & Scale FHI
Revenue Growth (YoY) N/A +8.1%
Earnings Growth (YoY) N/A +11.9%
TTM Revenue (USD) N/A $1.97B
Market Cap N/A $4.7B
3. Profitability & Quality FHI
Gross Margin N/A 69.3%
Operating Margin N/A 27.8%
Net Profit Margin N/A 21.3%
Return on Equity (ROE) N/A 31.0%
4. Balance Sheet & Cash Flow FHI
Cash Generation (TTM) N/A $574M EBITDA
Cash Flow Margin N/A 29.1% EBITDA Mgn
Net Cash / Leverage N/A ROE $18.32 Book/Sh · 31.0% ROE
Dividend Yield None (0.00%) 2.27%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile N/A (N/A) 22.1% (3rd %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Distribution NEUTRAL · Neutral
6. R&D & Supply-Chain Moat FHI
OpEx & R&D Intensity N/A 41.5% of Rev ($818M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Investment Advice Operator Asset Management Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: KKRT (1) vs FHI (9)
Institutional Metric KKRT FHI Criterion Row Edge
Market Capitalization
Scale
N/A $4.7B Larger Scale FHI
Trailing P/E Ratio
Valuation
N/M 11.5x Lower Multiple FHI
Forward P/E Ratio
Valuation
N/M 10.5x Lower Multiple FHI
Revenue Growth (YoY)
Growth
N/A +8.1% Higher Growth FHI
Operating Margin (TTM)
Profitability
N/A 27.8% Higher Margin FHI
Net Profit Margin
Profitability
N/A 21.3% Higher Margin FHI
Return on Equity (ROE)
Capital Efficiency
N/A 31.0% Higher ROE FHI
52-Week Range Position
Momentum
16% ($22–$26) 70% ($47–$67) Stronger Trend FHI
Beta / 30D Volatility
Risk Regime
0.25β · 16% Vol 0.57β · 38% Vol Lower Realized Risk KKRT
Unified Institutional Score
Composite Signal
43.2 / 100 (HOLD) 49.8 / 100 (HOLD) Higher Composite FHI
Trailing 12M Revenue (USD)
Operating Scale
N/A $1.97B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 69.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 1.50x PEG · 2.4x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $574M EBITDA ($18.32 Book/Sh · 31.0% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon FHI +11.88 pp
KKRT: -0.97% · FHI: +10.91%
3M Horizon KKRT +1.78 pp
KKRT: -2.44% · FHI: -4.22%
6M Horizon FHI +22.61 pp
KKRT: -8.54% · FHI: +14.07%
1Y Horizon FHI +37.78 pp
KKRT: -13.13% · FHI: +24.65%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KKRT vs FHI. Trailing 12-month operating profitability (KKRT N/A vs FHI 27.8%) and valuation multiples (KKRT N/M vs FHI 10.5x Forward P/E) are benchmarked directly in Pillar 4 below.

KKRT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
FHI ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.97B
Gross Margin69.3%
Op. Margin27.8%
ROE / Fwd P/E31.0% · 10.5x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
KKRT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KKRT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
FHI UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 22.1%
IV Percentile 3rd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact FHI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
KKRT Moat Profile Cyclical / Execution-Driven Positioning
Investment Advice Operator
Competes within the Investment Advice value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
FHI Moat Profile Scale & Operating Efficiency Moat
Asset Management Operator
Competes within the Asset Management value chain with $4.7B market capitalization and 27.8% operating margin.
OpEx & R&D Reinvestment 41.5% of Rev ($818M)
90D Engineering Disclosures 0 Published

Investor FAQ KKRT vs FHI Key Questions & Quantitative Answers

As of Nov 17, 2026, Federated Hermes, Inc. (FHI) is the stronger overall head-to-head candidate over KKR & Co. Inc. 6.875% Subordinated Notes due 2065 (KKRT) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). KKRT carries a Unified Composite Score of 43.2/100 (HOLD) at $22.37 (N/M Forward P/E, N/A operating margin), whereas FHI carries 49.8/100 (HOLD) at $61.28 (10.5x Forward P/E, 27.8% operating margin). Technical & Structure Timing Caution: KKRT is currently in a Weinstein Distribution regime near a flattening 50-day moving average (RSI 47.0); meanwhile FHI trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

FHI leads the Growth & Scale pillar: KKRT posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with FHI at +8.1% YoY revenue growth and +11.9% YoY earnings growth on $1.97B TTM revenue (69.3% gross margin, 27.8% operating margin). On trailing 12-month operating scale, KKRT generates N/A in USD-normalized revenue versus $1.97B for FHI. In operating R&D and SG&A reinvestment, KKRT deploys N/A (0 90-day corporate R&D disclosures) versus 41.5% of Rev ($818M) (0 disclosures) for FHI.

FHI screens cheaper on headline valuation multiples. KKRT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas FHI trades at 10.5x Forward P/E, 11.5x Trailing P/E, 1.50x PEG, and 2.4x EV/Revenue (29.1% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against KKRT (N/A ROE) versus FHI (31.0% ROE) capital efficiency.

In options market volatility and institutional positioning, KKRT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 16% Vol realized risk). By comparison, FHI carries 22.1% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.57β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.